IndiviorINDV
About: Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Employees: 1,164
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 8 (+4) [Q4]
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
70% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 23
19% more capital invested
Capital invested by funds: $817M [Q3] → $974M (+$158M) [Q4]
9% more funds holding
Funds holding: 102 [Q3] → 111 (+9) [Q4]
8.29% more ownership
Funds ownership: 53.65% [Q3] → 61.94% (+8.29%) [Q4]
2% more call options, than puts
Call options by funds: $831K | Put options by funds: $811K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Piper Sandler David Amsellem 51% 1-year accuracy 18 / 35 met price target | 36%upside $13 | Overweight Maintained | 6 Mar 2025 |
Financial journalist opinion
Based on 12 articles about INDV published over the past 30 days
